Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel
Introduction: Praziquantel (PZQ) is the only commercially available drug for schistosomiasis. The current shortage of alternative effective drugs and the lack of successful preventive measures enhance its value. The increase in the prevalence of PZQ resistance under sustained drug pressure is, there...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Instituto Nacional de Salud
2022-03-01
|
| Edice: | Biomédica: revista del Instituto Nacional de Salud |
| Témata: | |
| On-line přístup: | https://revistabiomedica.org/index.php/biomedica/article/view/5913 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|